Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 25,000 shares at $30.00 ($750K) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Scheduled sale ($750k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |